ClinicalTrials.Veeva

Menu

New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis (IRM-SLA)

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Amyotrophic Lateral Sclerosis

Treatments

Other: Muscular MRI
Other: Brain MRI
Other: Spinal cord MRI
Other: Electrophysiological exam

Study type

Interventional

Funder types

Other

Identifiers

NCT04691011
2020-50

Details and patient eligibility

About

Amyotrophic lateral sclerosis (ALS) is a disabling and rapidly progressive neurodegenerative disorder. There is no treatment that significantly slows progression. Our project aims to find new biomarkers in MRI at three levels: cerebral, medullary and muscular. These markers could allow an earlier diagnosis of the disease by showing more specific lesions of ALS and to quantify these lesions to measure the progression of the disease. This study will use advanced Magnetic Resonance Imaging (MRI) techniques High field (3T) and very high field (7T) MRI. Results from neurological and electrophysiological tests will be compared to the MRI. Subjects will be recruited from ALS center of Marseille, France. MRI will be done on ALS patients at baseline, at 3 month and at 6 month intervals.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients will be adults with a diagnosis of ALS.
  • Healthy controls will also be recruited and will be age- and gender-matched to patients.
  • Patients able to undergo a brain MRI for approximately an hour.

Exclusion criteria

  • Subjects with other psychiatric or CNS or PNS diseases.
  • Subjects ineligible for MRI investigation due to a pacemaker or other metallic foreign body, or significant claustrophobia that could affect the ability to have an MRI scan.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 3 patient groups

Muscle
Other group
Treatment:
Other: Electrophysiological exam
Other: Muscular MRI
Spinal cord
Other group
Treatment:
Other: Electrophysiological exam
Other: Spinal cord MRI
Other: Muscular MRI
Brain
Other group
Treatment:
Other: Electrophysiological exam
Other: Brain MRI
Other: Muscular MRI

Trial contacts and locations

1

Loading...

Central trial contact

Shahram Attarian; Jean Olivier Arnaud

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems